Ionis Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
All right. I want to thank everyone for joining us today. This is Kevin DeGeeter with Oppenheimer. The next presenting company is Ionis. And it's going to be structured as a fireside chat.
So going to look to just jump right in. Eric, maybe you can just briefly introduce yourself and maybe give us the 60-second overview of the Ionis ASO technology platform? Sure.
Thanks for having me on, Kevin. I appreciate the opportunity to chat. So I'm Eric Swayze. I am the Head of Research at Ionis. A long time Ionis veteran, I've been here since 1994 and have been heavily involved in bringing the technology forward. So on a medicinal chemist by training and started off trying to make better building blocks for antisense oligonucleotides.
And the 60-second overview is we make precision genetic medicines. They're designed to bind to the -- to all forms -- any form of RNA, which is the intermediary
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |